Examinant per Autoria "Servitja Tormo, Sonia"
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert Assessment of early therapy discontinuation and health-related quality of life in breast cancer patients treated with aromatase inhibitors: B-ABLE cohort study(Springer, 2019) Pineda-Moncusí, Marta; Servitja Tormo, Sonia; Tusquets Trias de Bes, Ignacio; Díez Pérez, Adolfo; Rial, Abora; Cos, Maria Lourdes; Campodarve, Isabel; Rodriguez-Morera, Jaime; Garcia Giralt, Natàlia; Nogués Solan, Francesc Xavier
Ítem Accés Obert Biomarkers expression in benign breast diseases and risk of subsequent breast cancer: a case-control study(Wiley, 2017) Posso, Margarita; Corominas Torres, Josep Maria; Serrano, Laia; Román, Marta; Torá Rocamora, Isabel, 1979-; Domingo, Laia; Romero, Anabel; Quintana, María Jesús; Vernet-Tomás, Maria; Baré, Marisa; Vidal, Carmen; Sánchez, Mar; Saladié, Francina; Natal, Carmen; Ferrer, Joana; Servitja Tormo, Sonia; Sala, Maria; Castells, Xavier; BELE Study Group
Ítem Accés Obert Bone health evaluation one year after aromatase inhibitors completion(Elsevier, 2018) Pineda-Moncusí, Marta; Servitja Tormo, Sonia; Casamayor, Guillem; Cos, Maria Lourdes; Rial, Abora; Rodriguez-Morera, Jaime; Tusquets Trias de Bes, Ignacio; Díez Pérez, Adolfo; Garcia Giralt, Natàlia; Nogués Solan, Francesc Xavier
Ítem Accés Obert Breast cancer risk after diagnosis by screening mammography of nonproliferative or proliferative benign breast disease: a study from a population-based screening program(Springer, 2015) Castells, Xavier; Domingo, Laia; Corominas Torres, Josep Maria; Torá Rocamora, Isabel, 1979-; Quintana, María Jesús; Baré, Marisa; Vidal, Carmen; Natal, Carmen; Sánchez, Mar; Saladié, Francina; Ferrer, Joana; Vernet, Mar; Servitja Tormo, Sonia; Rodríguez Arana, Ana Maria; Román, Marta; Espinàs, Josep Alfons; Sala, Maria
Ítem Accés Obert Clinical and histologic characteristics of breast cancers in women with previous pathologic diagnosis of benign breast disease in Spain(Wiley-Blackwell, 2018) Román, Marta; Caicoya, Martin; Espinàs, Josep Alfons; Sala Serra, Maria; Torá Rocamora, Isabel, 1979-; Quinta, Maria J.; Vernet-Tomás, Maria; Saladié, Francina; Romero, Anabel; Sánchez, Mar; Baré, Marisa; Vidal, Carmen; Servitja Tormo, Sonia; Natal, Carmen; Corominas Torres, Josep Maria; Ferrer, Joana; Rodríguez Arana, Ana Maria; Castells, Xavier; BELE Study Group
Ítem Accés Obert Defective Cyclin B1 Induction in Trastuzumab-emtansine (T-DM1) Acquired Resistance in HER2-positive Breast Cancer(American Association for Cancer Research (AACR), 2017) Sabbaghi Mehrjardi, Mohammad Ali; Gil Gómez, Gabriel; Guardia Laguarta, Cristina; Servitja Tormo, Sonia; Arpí Llucià, Oriol; Menendez Romero, Silvia; Arumí, Montserrat; Serrano, Laia; Salido Galeote, Marta; Muntasell i Castellví, Aura, 1972-; Martínez-García, Maria; Tusquets Trias de Bes, Ignacio; Rovira Guerín, Ana; Albanell Mestres, Joan
Ítem Accés Obert Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-κB target genes in human breast cancer(Impact Journals, 2014) Dalmases Massegú, Alba, 1982-; González González, Irene; Menendez Romero, Silvia; Arpí Llucià, Oriol; Corominas Torres, Josep Maria; Servitja Tormo, Sonia; Tusquets Trias de Bes, Ignacio; Chamizo, Cristina; Rincón, Raúl; Espinosa Blay, Lluís; Bigas Salvans, Anna; Eroles, Pilar; Furriol, Jessica; Lluch, Ana; Rovira Guerín, Ana; Albanell Mestres, Joan; Rojo, Federico
Ítem Accés Obert Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis(Springer, 2022) Vazquez, Juan Carlos; Antolin, Silvia; Ruiz-Borrego, Manuel; Servitja Tormo, Sonia; Alba, Emilio; Barnadas, Agustí; Lluch, Ana; Martín, Miguel; Rodríguez-Lescure, Álvaro; Solà, Ivan; Bonfill, Xavier; Urrutia, Gerard; Sanchez-Rovira, Pedro
Ítem Accés Obert Evolución de la DMO durante el tratamiento con inhibidores de aromatasa y su relación con el gen CYP11A1: estudio prospectivo de la cohorte B-ABLE(Sociedad Española de Investigación Ósea y del Metabolismo Mineral, 2015) Rodríguez Sanz, Maria, 1984-; Prieto-Alhambra, Daniel; Servitja Tormo, Sonia; Garcia Giralt, Natàlia; Garrigós, Laia; Albanell Mestres, Joan; Martinez-García, Maria; González, I.; Martos, Tamara; Díez Pérez, Adolfo; Tusquets Trias de Bes, Ignacio; Nogués Solan, Francesc Xavier
Ítem Accés Obert Expert consensus to optimize the treatment of elderly patients with luminal metastatic breast cancer(Springer, 2022) Torregrosa-Maicas, Maria Dolores; Barco Berrón, Sonia del; Cotes Sanchís, Almudena; Lema Roso, L.; Servitja Tormo, Sonia; Gironés i Sarrió, Regina
Ítem Accés Obert Increased fracture risk in women treated with aromatase inhibitors versus tamoxifen: beneficial effect of bisphosphonates(Wiley, 2020) Pineda-Moncusí, Marta; Garcia Giralt, Natàlia; Díez Pérez, Adolfo; Servitja Tormo, Sonia; Tusquets Trias de Bes, Ignacio; Prieto-Alhambra, Daniel; Nogués Solan, Francesc Xavier
Ítem Accés Obert Interplay between Natural killer cells and Anti-HER2 antibodies: Perspectives for breast cancer immunotherapy(Frontiers, 2017) Muntasell i Castellví, Aura, 1972-; Cabo, Mariona, 1991-; Servitja Tormo, Sonia; Tusquets Trias de Bes, Ignacio; Martínez-García, Maria; Rovira Guerín, Ana; Rojo, Federico; Albanell Mestres, Joan; López-Botet, M. (Miguel)
Ítem Accés Obert LCOR mediates interferon-independent tumor immunogenicity and responsiveness to immune-checkpoint blockade in triple-negative breast cancer(Nature Research, 2022) Pérez-Núñez, Iván; Rozalén, Catalina; Palomeque, José Ángel; Sangrador, Irene; Dalmau, Mariona; Comerma Blesa, Laura, 1983-; Hernández Prat, Anna, 1984-; Casadevall Aguilar, David; Menendez Romero, Silvia; Liu, Dan; Berenguer De Felipe, Jordi; Peña Arranz, Raúl, 1976-; Montañés, José Carlos; Albà Soler, Mar; Bonnin, Sarah; Ponomarenko, Julia; Servitja Tormo, Sonia; Arribas, Joaquín; Albanell Mestres, Joan; Celià-Terrassa, Toni
Ítem Accés Obert Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry(Springer, 2023) Martín, Miguel; Servitja Tormo, Sonia; Aguiar-Bujanda, David
Ítem Accés Obert NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer(BioMed Central, 2024) Santana-Hernández, Sara; Suárez Olmos, Jesús; Servitja Tormo, Sonia; Berenguer-Molins, Pau; Costa García, Marcel, 1989-; Comerma Blesa, Laura, 1983-; Rea, Anna; Perera Bel, Júlia; Menendez Romero, Silvia; Arpí Llucià, Oriol; Bermejo, Begoña; Martínez, María Teresa; Cejalvo, Juan Miguel; Comino-Méndez, Iñaki; Pascual, Javier; Alba, Emilio; López-Botet, M. (Miguel); Rojo, Federico; Rovira, Ana; Albanell Mestres, Joan; Muntasell i Castellví, Aura, 1972-
Ítem Accés Obert Non-canonical NF-κB pathway activation predicts outcome in borderline oestrogen receptor positive breast carcinoma(Nature Research, 2016) Rojo, Federico; González-Pérez, Abel; Furriol, Jessica; Nicolau, Ma Jesús; Ferrer, Jaume; Burgués, Octavio; Sabbaghi Mehrjardi, Mohammad Ali; González Navarrete, Irene, 1983-; Cristóbal, Ion; Serrano, Laia; Zazo, Sandra; Madoz-Gúrpide, Juan; Servitja Tormo, Sonia; Tusquets, Ignasi; Albanell Mestres, Joan; Lluch, Ana; Rovira Guerín, Ana; Eroles, Pilar
Ítem Accés Obert Palbociclib combined with endocrine therapy in heavily pretreated HR +/HER2 - advanced breast cancer patients: results from the compassionate use program in Spain (PALBOCOMP)(Elsevier, 2020) Manso, Luis; Servitja Tormo, Sonia; Moreno, Fernando
Ítem Accés Obert Palinopsia associated with the CDK4/6 inhibitor ribociclib during the first-line treatment of metastatic breast cancer: two case reports(Frontiers, 2024) Martos, Tamara; Saint-Gerons Trecu, Marta; Masfarré, Laura; Castro-Henriques, Maria; Martínez-García, Maria; Servitja Tormo, Sonia; Albanell Mestres, Joan
Ítem Accés Obert Prevalence of homologous recombination deficiency among patients with germline RAD51C/D breast or ovarian cancer(American Medical Association, 2024) Torres-Esquius, Sara; Servitja Tormo, Sonia; Balmaña, Judith
Ítem Accés Obert SEOM clinical guidelines in early stage breast cancer (2018)(SpringerOpen, 2019) Ayala de la Peña, Francisco ; Andrés, Raquel; Garcia-Saenz, José Angel; Manso, Luis; Margeli, M. E.; Dalmau, M. E.; Pernas, S.; Prat, Aleix; Servitja Tormo, Sonia; Ciruelos, Eva